×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS20 New Phase in Combatting Antimicrobial Resistance (AMR)
Session Chair(s)
Masahito Nagashima
Head of Clinical Research
Pfizer R&D Japan, Japan
Speaker(s)
Shigeru Omi, MD, PhD
Japan Anti-Tuberculosis Association, Japan
Representative Director
Kazuhiro Tateda, MD, PhD
Toho University, Japan
Professor, Department of Microbiology and Infectious Diseases
Mari Ariyasu
Shionogi & Co., Ltd., Japan
Head of Project Management 4, Senior Director